Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid - 13/06/12
Abstract |
Lamotrigine (LTG) is a novel antiepileptic drug effective in partial and generalized seizures. Recently, this drug has started being used for mood stabilization in psychiatric patients. Cutaneous side effects of this drug are mostly maculopapular eruptions that have been seen in 3% to 10% of patients. We describe a 33-year-old female patient in whom Stevens-Johnson syndrome (SJS) developed because of LTG. The drug was discontinued, and patient's signs and symptoms progressively resolved in 10 days after oral prednisolone therapy. The case is relevant because this is the first case of SJS as a result of LTG, probably associated with concomitant use of valproic acid and neuroleptic drugs. (J Am Acad Dermatol 2000;43:898-9.)
Le texte complet de cet article est disponible en PDF.Plan
 | This supplement is made possible through an educational grant from Ortho Dermatological to the American Academy of Dermatology. |
| Reprint requests: Basak Yalçin, MD, 25 Hacettepe University, Department of Dermatology, Sihhiye, Ankara, 06100, Turkey. |
 | J Am Acad Dermatol 2000;43:898-9. |
Vol 43 - N° 5P2
P. 898-899 - novembre 2000 Retour au numéro
Article précédent
- Segmental neurofibromatosis in association with nevus sebaceus of Jadassohn
- Jason R. Lupton, Mervyn L. Elgart, Virginia I. Sulica
- Mast cells in an angiosarcoma complicating Xeroderma pigmentosum in a 13-year-old girl
- Dagmar Ludolph-Hauser, Eva Thoma-Greber, Christian Sander, Christian P. Sommerhoff, Martin Röcken
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?